Results 241 to 250 of about 42,588 (295)

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly  

Breast Cancer Statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Hyuna Sung, Kimberly D Miller, Rebecca L Siegel   +2 more
exaly  

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Vagal nerve activity and sympathetic nerve activity are suppressed by alpha-2 adrenergic receptor agonists in conscious rats

, 2023
Kenju Miki, Shizuka Ikegame, Misa Yoshimoto   +2 more
openalex   +1 more source

Preoperative alpha sub 2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery

, 1996
P. J. Kulka, M. Tryba, M. Zenz
openalex   +1 more source

Alpha 2-adrenergic receptors in neuroblastoma x glioma hybrid cells. Characterization with agonist and antagonist radioligands and relationship to adenylate cyclase.

, 1982
Daniel Kahn, J C Mitrius, D.C. U'Prichard   +2 more
openalex   +1 more source

Agonist-mediated regulation of alpha 1- and beta 2-adrenergic receptors in cloned MDCK cells

, 1985
Kathryn E. Meier, D. M. Sperling, Paul A. Insel   +2 more
openalex   +1 more source

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly